Antineoplastic Agents

Anastrozole treats breast cancer by inhibiting the production of estrogen in tissues of the body of post-menopausal women.
- By inhibiting the production of estrogen, the estrogen receptor [ER]-positive and/or progesterone receptor [PR]-positive cancer cells cannot grow.
- Anastrozole operates by blocking the aromatase enzyme that converts androgen to estrogen in the tissues of women who have gone through menopause.
- Postmenopausal women get estrogen from the conversion of androgen into estrogen in the tissues of the body.
- In women who have not gone through menopause, they receive their estrogen from the ovaries.
- Anastrozole is categorized pharmacologically as an antineoplastic agent and as a nonsteroidal aromatase inhibitor and is indicated for postmenopausal women. Anastrozole treats breast cancer by inhibiting the production of estrogen in tissues of the body of post-menopausal women.
- By inhibiting the production of estrogen, the estrogen receptor [ER]-positive and/or progesterone receptor [PR]-positive cancer cells cannot grow.
- Anastrozole operates by blocking the aromatase enzyme that converts androgen to estrogen in the tissues of women who have gone through menopause.
- Postmenopausal women get estrogen from the conversion of androgen into estrogen in the tissues of the body.
- In women who have not gone through menopause, they receive their estrogen from the ovaries.
- Anastrozole is categorized pharmacologically as an antineoplastic agent and as a nonsteroidal aromatase inhibitor and is indicated for postmenopausal women.

Letrozole (Femara) is an antineoplastic agent. Antineoplastic agents are anticancer medications. Letrozole is also categorized as a nonsteroidal aromatase inhibitor. Aromatase inhibitors do not allow the aromatase enzyme to convert androgen into estrogen in the tissues. By blocking estrogen production in the tissues of the body, the estrogen receptor [ER]-positive and/or progesterone receptor [PR]-positive) breast cancer cells cannot grow. Letrozole (Femara) is an antineoplastic agent. Antineoplastic agents are anticancer medications. Letrozole is also categorized as a nonsteroidal aromatase inhibitor. Aromatase inhibitors do not allow the aromatase enzyme to convert androgen into estrogen in the tissues. By blocking estrogen production in the tissues of the body, the estrogen receptor [ER]-positive and/or progesterone receptor [PR]-positive) breast cancer cells cannot grow.